Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity

Por Chen, Zhenghu, Wang, Zhenyu, Pang, Jonathan C., Yu, Yang, Bieerkehazhi, Shayahati, Lu, Jiaxiong, Hu, Ting, Zhao, Yanling, Xu, Xin, Zhang, Hong, Yi, Joanna S., Liu, Shangfeng, Yang, Jianhua
Publicado no Sci Rep (2016)

Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma

Por Lu, Jiaxiong, Guan, Shan, Zhao, Yanling, Yu, Yang, Wang, Yongfeng, Shi, Yonghua, Mao, Xinfang, Yang, Kristine L., Sun, Wenjing, Xu, Xin, Yi, Joanna S., Yang, Tianshu, Yang, Jianhua, Nuchtern, Jed G.
Publicado no Oncotarget (2016)

Structure-Guided DOT1L Probe Optimization by Label-Free Ligand Displacement

Por Yi, Joanna S., Federation, Alexander J., Qi, Jun, Dhe-Paganon, Sirano, Hadler, Michael, Xu, Xiang, St. Pierre, Roodolph, Varca, Anthony C., Wu, Lei, Marineau, Jason J., Smith, William B., Souza, Amanda, Chory, Emma J., Armstrong, Scott A., Bradner, James E.
Publicado no ACS Chem Biol (2014)

Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling

Por Bieerkehazhi, Shayahati, Chen, Zhenghu, Zhao, Yanling, Yu, Yang, Zhang, Huiyuan, Vasudevan, Sanjeev A., Woodfield, Sarah E., Tao, Ling, Yi, Joanna S., Muscal, Jodi A., Pang, Jonathan C., Guan, Shan, Zhang, Hong, Nuchtern, Jed G., Li, Hui, Li, Huiwu, Yang, Jianhua
Publicado no Oncotarget (2016)